KORTUC Phase 1 study is commenced in the UK

A Phase 1 study for locally advanced/recurrent breast cancer to evaluate the safety and tolerability of KORTUC (a novel radiation sensitizer) was started in the Royal Marsden Hospital in the UK.

Further information can be found below